100 results
Page 2 of 5
8-K
EX-99.1
ft6 eh7x1jy3x0l
15 Aug 23
Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System
8:30am
8-K
EX-99.1
bqvrtwkq9
10 Aug 23
Regulation FD Disclosure
9:18am
8-K
EX-99.1
s1o6506
25 Jul 23
Engagement includes audit plans for ISO 13485 certification, to pave the way for obtaining CE Mark for clearance of sales in the European Union
9:15am
424B3
clqnbtx p9upi7mimos7
18 Jul 23
Prospectus supplement
2:48pm
8-K
EX-99.1
63szmalcg 0qkzga18c5
11 Jul 23
Regulation FD Disclosure
8:30am
8-K
EX-99.1
to5czf0
29 Jun 23
Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US
8:30am
8-K
EX-99.2
vvv8ibh
28 Jun 23
Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
6:13pm
8-K
EX-99.1
akvq1d24w0ocxa 983x
28 Jun 23
Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
6:13pm
424B5
j4fr s4p2ho8z2lg9phm
28 Jun 23
Prospectus supplement for primary offering
7:14am
8-K
EX-99.1
wif1nl7 5abxst
22 Jun 23
Received Grant of Protection for a Design Patent in Japan Covering its Innovative LIBERTY® Robotic Drive
8:30am
8-K
EX-99.1
k6rvo6ju1
16 Jun 23
Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe
8:30am
8-K
EX-99.2
5f5v8y
6 Jun 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-99.1
zib6 7miw
6 Jun 23
Entry into a Material Definitive Agreement
5:03pm
424B5
vnqgt0kmi5
5 Jun 23
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
41key 1cvc
2 Jun 23
Regulation FD Disclosure
8:26am
8-K
EX-99.1
klesm2nqxms 4mn6vj4
31 May 23
LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process
8:30am
8-K
EX-99.1
f1z05
25 May 23
This Significant Achievement Represents Major Progression Toward Regulatory and Commercialization Paths
10:07am
8-K
EX-99.2
6qd56
24 May 23
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:32pm
8-K
EX-99.1
ekv0ihzb
24 May 23
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:32pm